Skip to main
PATH

UiPath (PATH) Stock Forecast & Price Target

UiPath (PATH) Analyst Ratings

Based on 15 analyst ratings
Hold
Strong Buy 13%
Buy 0%
Hold 80%
Sell 7%
Strong Sell 0%

Bulls say

UiPath Inc demonstrated strong financial performance with total revenue of $481.1 million, representing a 14% year-over-year increase and exceeding estimates. The company reported a total Remaining Performance Obligations (RPO) of $1.475 billion, up 19% year-over-year, while the Annualized Renewal Run-rate (ARR) reached $1.853 billion, reflecting an 11% increase. Notably, the growth in customers with over $100K ARR by 12% year-over-year, along with improved RPO metrics, underscores a positive trajectory for UiPath's operational and financial strength.

Bears say

UiPath Inc. faces a negative outlook primarily due to a broad-based selloff in the software industry, which has led to reduced price targets and multiple compressions. The company's revenue growth and margin projections are under pressure, with significant risk stemming from potential declines in tech spending, new customer acquisition challenges, and lower renewal and expansion rates in the next fiscal years. Additionally, prolonged timelines for achieving GAAP breakeven may diminish the present value of future cash flows, further negatively impacting the valuation of UiPath's shares amidst a competitive technology landscape.

UiPath (PATH) has been analyzed by 15 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 0% recommend Buy, 80% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UiPath and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UiPath (PATH) Forecast

Analysts have given UiPath (PATH) a Hold based on their latest research and market trends.

According to 15 analysts, UiPath (PATH) has a Hold consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.27, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.27, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UiPath (PATH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.